Belgian centre rules on multibillion pharma fraud claim
A US pharmaceutical company says it has prevailed in what is thought to be the largest-ever case heard at Belgian arbitral institution CEPANI, concerning alleged fraud during a US$4.3 billion acquisition.
To read more
Subscribe to Global Arbitration Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Arbitration Review experts.